---
document_datetime: 2023-09-21 20:54:52
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/riltrava-aerosphere-epar-all-authorised-presentations_en.pdf
document_name: riltrava-aerosphere-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.7593006
conversion_datetime: 2025-12-19 02:01:53.447655
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name     | Strength               | Pharmaceutical Form                | Route of Administration   | Immediate Packaging         | Pack size                                   |
|------------------|---------------------|------------------------|------------------------------------|---------------------------|-----------------------------|---------------------------------------------|
| EU/1/21/1604/001 | Riltrava Aerosphere | 5 µg / 7.2 µg / 160 µg | Pressurised inhalation, suspension | Inhalation use            | inhaler (aluminium/plastic) | 1 inhaler (120 actuations)                  |
| EU/1/21/1604/002 | Riltrava Aerosphere | 5 µg / 7.2 µg / 160 µg | Pressurised inhalation, suspension | Inhalation use            | inhaler (aluminium/plastic) | 3 inhalers (3 x 120 actuations) (multipack) |